Anti-aging injection regrows knee cartilage and prevents arthritis

Original Article ↗ Hacker News Discussion ↗

An experimental “anti‑aging” therapy that inhibits the enzyme 15‑PGDH has been shown to regrow knee cartilage and reduce osteoarthritis pain in mice, and human knee tissue samples have also responded by forming new, apparently normal cartilage. Commenters are cautiously optimistic about its potential to delay or replace joint surgeries in people, while noting caveats such as cancer risks seen when similar pathways are altered in other tissues and the long road from animal studies to approved human treatments. In the meantime, many share strategies for managing arthritis and joint damage today, from tailored physical therapy, stretching, and gait changes to supplements, injections, and avoiding high‑impact activities.

Excitement vs. “in mice” caveat

  • Many are very excited, especially older readers and those with meniscus tears, arthritis, or thumb/hand issues.
  • Repeated reminder: results are in mice, though ex vivo human knee tissue reportedly also regrew cartilage and behaved “normally,” which some take as encouraging.
  • Others urge caution until actual human clinical outcomes are shown.

Mechanism and compounds

  • Discussion centers on inhibiting 15‑PGDH (“gerozyme”) to boost prostaglandin signaling and trigger cartilage regeneration and pain reduction.
  • The Science paper identifies the small molecule SW033291 as the 15‑PGDH inhibitor; no clinicaltrials.gov hits yet.
  • JAK‑STAT inhibitors are mentioned as also downregulating 15‑PGDH, but are expensive.
  • Some note 15‑PGDH inhibition can promote tumor growth in other tissues (e.g., pancreas), highlighting possible cancer risks.
  • A question about the relationship between 15‑PGDH and NAD+ goes unanswered (unclear).

Cartilage, aging, and other joints

  • Several call cartilage failure a key limiter of healthy lifespan, though others argue nerves (spinal, optic) are more critical.
  • People hope this will extend to ankles, hips, backs, and finger joints; one commenter notes ankles share similar cartilage type, so they’re optimistic but still speculative.

Current arthritis and joint management

  • Many personal stories: meniscus removal, early arthritis, hip and knee replacements, microfracture surgery, long-standing pain from sports or accidents.
  • Common themes:
    • Keep moving: “motion is lotion” – light activity often better than rest.
    • Low‑impact cardio (cycling, treadmill, trail running), weight management, and strengthening surrounding muscles.
    • NSAIDs (especially topical diclofenac), corticosteroid injections, DMARDs for rheumatoid disease, occasional mention of PRP and low‑dose radiation.
    • Some report dramatic improvement from targeted stretching or physical therapy, sometimes outperforming or delaying surgery.
    • One case of misdiagnosed “arthritis” turned out to be a staph infection.

Supplements and collagen debate

  • Claims that collagen synthesis can be supported by hydrolyzed collagen plus vitamin C, zinc, copper.
  • UC Davis/Keith Baar work is cited in favor of collagen/gelatin plus vitamin C for tendon/ligament health, with some strong personal anecdotes.
  • Others question mechanism (“why not just protein?”) and note a meta‑analysis suggesting positive collagen trials may be biased by funding. Several say they will stop supplementation.

Movement patterns and technique

  • Runners describe knee relief from:
    • Switching from heel‑strike to forefoot/ball‑of‑foot running.
    • Trail running or softer surfaces vs. concrete/asphalt.
  • Detailed discussion on trail technique, ankle strengthening, accepting walk sections, and the benefits of uneven terrain for stabilizing muscles.
  • Some argue cycling can also stress joints if bike fit is poor; others favor mixed or alternative activities (hiking, swimming, incline walking).

Hands, ergonomics, and overuse

  • Several hope for finger joint regeneration after decades of typing or music playing.
  • Mechanical and ergonomic keyboards, split layouts, very light springs (20g or less), and even capless switches are discussed as pain‑reduction strategies, with varying success.
  • Voice input and AI “typing for you” are suggested as partial workarounds.

Risk–benefit outlook

  • Many express hope this therapy could delay or replace joint replacements and maintain mobility into old age.
  • Others emphasize the need to balance regeneration with cancer risk and call for careful long‑term human studies before broad use.